“…Among the many proteins that are upregulated in reactive astrocytes, S100B is of particular interest in the context of PD because of its potential to initiate pathological processes in DA neurons during early stage PD. Indeed, extracellular S100B has been shown to alter neuronal activity in multiple brain regions (Morquette et al, 2015;Ryczko et al, 2021), and extracellularly secreted S100B from astrocytes accelerates neurodegeneration by engaging receptor for advanced glycation endproducts (RAGE)-mediated pro-inflammatory pathways on astrocytes and microglia (Hofmann et al, 1999;Huttunen et al, 2000;Riuzzi, Sorci, Beccafico, & Donato, 2012). In addition to signaling through RAGE receptors, S100B and the S100 family of proteins interact intracellularly with several ion channels and receptors expressed in neurons, and these interactions result in significant biological effects such as increased neurotropism or the modulation of neuronal excitability (Hermann, Donato, Weiger, & Chazin, 2012).…”